- US Capitol Capsule: Caution biopharma: wacky Washington wild ride ahead
- US Capitol Capsule: Obama superbug attack plan hinges on funding, cooperation
- EFPIA welcomes new EC structure, but others fear threat to data disclosure
- US Capitol Capsule: Dems target inversion earnings stripping; will Republicans play?
- Executive Profile: Luciano Rossetti, chief cartographer for Merck Serono's R&D roadmap
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade